Research Article
Screening for Nephropathy in Diabetes Mellitus: Is Micral-Test Valid among All Diabetics?
Table 1
Assessment of validity of Micral-test according to subgroups of diabetics.
| Cut-off value: 20 mg/L | Sensibility (%) | Specificity (%) | Kappa | | NPV | PLR | NLR |
| Entire population | 77.2 CI 95% [65.5–88.9] | 46.3 CI 95% [32.4–60.2] | 0.2 | 0.001 | 88.4 | 27.8 | | Gender: | | | | | | | | (i) Male | 66.6% | 46.6% | 0.103 | 0.008 | 77.7% | 1.2 | 0.74 | (ii) Female | 77% | 66% | 0.323 | 0.006 | 90.6% | 2.26 | 0.34 | BP ≥ 130/80 mmHg | 81% | 54.1% | 0.236 | 0.005 | 90.7% | 1.76 | 0.35 | CHT/C-HDL ratio ≥ 3 | 83.3% | 60.1% | 0.363 | 0.011 | 89.4% | 2.07 | 0.28 | T2D duration > 5 years | 91% | 60.6% | 0.378 | 0.001 | 95.2% | 2.27 | 0.15 |
|
|
NPV: negative predictive value. PLR: positive likelihood ratio. NLR: negative likelihood ratio.
|